982-P: A Double-Blinded, Placebo Controlled, Single Ascending Dose Study for Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics after Subcutaneous Administration of Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in Healthy Obese Subjects

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 982-P
Author(s):  
JAE DUK CHOI ◽  
SEUNGJAE BAEK ◽  
YOUNGMIN KIM ◽  
KAHEE EUN ◽  
SE CHANG KWON ◽  
...  
Keyword(s):  
Subcutaneous Administration ◽  
Pharmacokinetics And Pharmacodynamics ◽  
Dose Study ◽  
Obese Subjects ◽  
Healthy Obese ◽  
Long Acting ◽  
Double Blinded ◽  
Single Ascending Dose Study

A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056)

2012 ◽  
Vol 115 (2) ◽  
pp. 274-283 ◽  
Author(s):  
Laurie J. Antonik ◽  
D. Ronald Goldwater ◽  
Gavin J. Kilpatrick ◽  
Gary S. Tilbrook ◽  
Keith M. Borkett
Keyword(s):  
Phase I ◽  
Pharmacokinetics And Pharmacodynamics ◽  
Dose Study ◽  
Single Ascending Dose Study

107-LB: Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1092 in Healthy Subjects (HS)

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 107-LB
Author(s):  
LINDA MORROW ◽  
MICHAEL GRIMM ◽  
CARINE BEYSEN ◽  
GEOFFREY WALFORD ◽  
KELLY DUNCAN ◽  
...  
Keyword(s):  
Healthy Subjects ◽  
Pharmacokinetics And Pharmacodynamics ◽  
Dose Study ◽  
Single Ascending Dose Study
Sign in / Sign up

Export Citation Format

Share Document